Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-27

Clinical Trial Update: A Study to Investigate the Mechanistic Effects of Dapagliflozin Alone or in Combination With Balcinrenone, Compared to Balcinrenone and Placebo on Body Fluid and Electrolyte Handling and Energy Metabolism in Participants Over 50 Years of Age With Chronic Kidney Disease. [Phase 2]

View source ↗

Summary

Phase 2 trial investigating the mechanistic effects of dapagliflozin alone or with Balcinrenone on body fluid/electrolyte handling and energy metabolism in adul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Balcinrenone
  • Dapagliflozin (dapagliflozin)

Snippet

Sponsor: Klinikum Nürnberg | Conditions: Chronic Renal Failure, Mechanistic Effects of SGLT2 Inhibition and/ or MR Antagonism on Body Fluid and Electrolyte Homeostatis | Phase 2 | Status: COMPLETED